Signifor (pasireotide) is indicated for adult patients with Cushing's disease for whom surgery is not an option or for whom surgery has failed.
This information is based on the European Summary of Product Characteristics. The prescribing information in your country may vary; please consult your local prescribing information and/or contact your local Novartis representative.

